These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 799950)

  • 1. Kinetic response of human leukemic and lymphoma cells in vivo to combination chemotherapy using flow microfluorometry.
    Fried J; Arlin Z; Alikpala A; Tan CT; Clarkson B
    Cancer Treat Rep; 1976 Dec; 60(12):1937-46. PubMed ID: 799950
    [No Abstract]   [Full Text] [Related]  

  • 2. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
    Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy.
    Armitage JO; Corder MP; Leimert JT; Dick FR; Elliot TE
    Cancer Treat Rep; 1980; 64(4-5):649-54. PubMed ID: 7000347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A male with primary breast lymphoma.
    Miura Y; Nishizawa M; Kaneko H; Watanabe M; Tsudo M
    Am J Hematol; 2009 Mar; 84(3):191-2. PubMed ID: 18932237
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
    Killmann SA
    Schweiz Med Wochenschr; 1974 Feb; 104(8):278-84. PubMed ID: 4814680
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
    Sampi K; Honda T; Hattori M; Takayama S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell kinetics as related to treatment of patients with acute nonlymphoid leukemia.
    Lampkin BC
    Am J Pediatr Hematol Oncol; 1985; 7(4):358-72. PubMed ID: 2417503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
    Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM
    J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.
    Miles SA; McGratten M
    J Clin Oncol; 2005 Jan; 23(1):247-8. PubMed ID: 15625386
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy-induced transverse white lines in the fingernails.
    James WD; Odom RB
    Arch Dermatol; 1983 Apr; 119(4):334-5. PubMed ID: 6340614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary therapeutic results of treatment of non-Hodgkin lymphoma in children according to the BACOP program].
    Bogusławska-Jaworska J; Grześkowiak-Melanowska J; Kaczmarek M; Kościelniak E; Legutko L; Sońta-Jakimczyk D; Sroczyńska M; Wojcik Z
    Pediatr Pol; 1980 Feb; 55(2):207-10. PubMed ID: 6154919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
    Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
    Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
    Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M;
    Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
    Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
    Laver JH; Kraveka JM; Hutchison RE; Chang M; Kepner J; Schwenn M; Tarbell N; Desai S; Weitzman S; Weinstein HJ; Murphy SB
    J Clin Oncol; 2005 Jan; 23(3):541-7. PubMed ID: 15659500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
    Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
    Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary mediastinal large B-cell lymphoma.
    Faris JE; LaCasce AS
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):125-33. PubMed ID: 19367254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia.
    Park CH; Amare M; Morrison FS; Maloney TR; Goodwin JW
    Cancer Treat Rep; 1982 Jun; 66(6):1257-61. PubMed ID: 7083232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.